Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins

作者：Douglas D. Bradley, John Wingerd, Diana B. Petitti, Ronald M. Krauss, Savitri Ramcharan · 发表于：New England Journal of Medicine · 年份：1978 · DOI：10.1056/nejm197807062990104 · 被引用次数：432 · 研究领域：Reproductive Health and Contraception、Menopause: Health Impacts and Treatments、Hormonal and reproductive studies

To determine the associations between high-density-lipoprotein cholesterol levels and use of oral contraceptives or of noncontraceptive estrogens and progestins we analyzed the serum levels of this lipid in 4978 women, 21 to 62 years of age. In estrogen users, the mean level was 6.7 to 15.1 mg per deciliter above the nonuser level (P less than 0.001), whereas in a group of progestin users it was 15.8 mg per deciliter below (P less than 0.001). In women using combination oral contraceptives, the level varied with the type and dose of the component steroids, in general increasing with increasing dose of estrogen and decreasing with increasing dose or potency of progestin. Thus, the net effect of use of a combination oral contraceptive on high-density-lipoprotein cholesterol depends on its formulation.